updates from the defifrance study
Published 2 years ago • 31 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
2:47
update on the defifrance study from eha
-
1:07
final results of a phase ii study of add-on parsaclisib for pts with mf and suboptimal rux response
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:46
personalized treatments to manage post-transplantation outcomes in aml: insights from morpho
-
21:38
drawing the line: the rationale behind blood tube collection order
-
26:46
webinar recording | technology advances in hematology testing | sparrc 2021 by srmc | mindray india
-
3:34
ash news tv 2023: e. donnall thomas lecture and prize
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
2:09
advancing cml treatment: novel drugs, personalized treatment strategies, and improving tfr
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
0:54
a research update in richter's transformation from ash 2023
-
0:44
the recent fda approval of ponatinib for ph all following success in the phallcon trial
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
2:41
an overview of the latest advances in hematology
-
1:57
impact of age on treatment outcomes in b-cell all
-
1:11
the treatment of aml within the united kingdom nhs framework
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:00
current and emerging treatment options for anemia in mf